# FDA Inspection 1169023 - Marlinz Pharma, LLC - May 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/marlinz-pharma-llc/4b5ea71f-b7cf-4f34-b34b-5fea311505bb
Source feed: FDA_Inspections

> FDA Inspection 1169023 for Marlinz Pharma, LLC on May 04, 2022. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169023
- Company Name: Marlinz Pharma, LLC
- Inspection Date: 2022-05-04
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1008957 - 2017-02-09](https://www.keypedia.com/records/fda_inspections/marlinz-pharma-llc/8598920e-c38a-461c-be40-87fa2ffa741b)

Company: https://www.keypedia.com/companies/marlinz-pharma-llc/66897e87-8f53-4e28-86b4-e6db39fd3dce

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c